Colorectal Cancer Clinical Trials
M24-064
Phase 3 Colorectal Cancer.
ABBVIE M24-533
M24-533: A Phase 2, Open-Label, Randomized, Master Protocol Study to Evaluate Safety and Efficacy of Multiple Treatment Combinations with ABBV-400 in Subjects with Metastatic Colorectal Cancer.
TAK-113-4002
A trial to evaluate the safety and activity of fruquintinib in minority populations with advanced, previously treated colorectal cancer. A Single Arm Phase 4 Trial to Evaluate the Safety and Efficacy of Oral Fruquintinib in the Treatment of Refractory Metastatic. Colorectal Cancer in Patients from Minority Populations Underrepresented in Prior Fruquintinib Studies.
Pfizer C6461003
An Interventional, Phase 3, Double-Blind, Randomized Study To evaluate The Efficacy And Safety Of Pf-08634404 In Combination With Chemotherapy Versus Bevacizumab In Combination With chemotherapy In Treatment-Naïve Participants With metastatic Colorectal Cancer